BENZENO SHARON

Insider

Chief Business Development Off

Trades at: ADPT

30D 90D 1Y

Net shares · 365d

-682.1K

0 buy · 682.1K sell

Net value · 365d

-$11.2M

$0 in · $11.2M out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 682.1K sell

Trading track record · all companies

Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.

Transactions · 365d

Open-market Buys Sells All types

ADPT Sell·S
Mar 11, 26

Chief Commercial Ofc Imm Med

$831.1K

63.1K sh · $13.17

Own -19%
ADPT Sell·S
Dec 4, 25

Chief Commercial Ofc Imm Med · 10b5-1

$212.4K

12.6K sh · $16.85

Own -4%
ADPT Sell·S
Nov 21, 25

Chief Commercial Ofc Imm Med · 10b5-1

$10.1M

606.4K sh · $16.73 avg · 2 lots

Own -67%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
Mar 11, 2026	ADPT	Chief Commercial Ofc Imm Med	Sell S	63.1K	-19%	$13.17	$831.1K
Dec 4, 2025	ADPT	Chief Commercial Ofc Imm Med	Sell S	12.6K	-4%	$16.85	$212.4K
Nov 21, 2025	ADPT	Chief Commercial Ofc Imm Med	Sell S	606.4K2 lots	-67%	$16.73 avg	$10.1M

Buy Sell Non-market (grant · exercise · gift)

About BENZENO SHARON

This profile aggregates every SEC Form 4 insider transaction reported by BENZENO SHARON across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.